In the most comprehensive and integrative study including 625 patients with AML, they found that B7H3 expression was essentially regulated by DNA methylation, and it was associated with old age, TP53 mutations, and a poor outcome in four independent datasets. This evidence concerns the gene TP53 and acute myeloid leukemia.